New research demonstrates that delivery of engineered therapeutic dendritic cells that target lymphoid sites of tolerance induction can compensate for failing tolerance in the patient.
Dendritic Cells in Treatment for Type 1 Diabetes
Jun 11, 2014 1:00:47 PM / by Maria posted in immune system, type 1 diabetes, Basic Research